Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recurrent vulvar cancer.

Emery M Salom1, Manuel Penalver

  • 1University of Miami, Jackson Memorial Hospital, Division of Gynecologic Oncology, 1611 NW 12 Avenue, East Tower, Room 3003, Miami, FL 33136, USA.

Current Treatment Options in Oncology
|June 12, 2002
PubMed
Summary

Recurrent vulvar cancer treatment varies by location. Surgery is key for local recurrences, while chemoradiation is vital for pelvic recurrences, improving survival and reducing morbidity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Testosterone Therapy in Women: A Literature Review of Clinical Indications, Dosing, Routes of Administration, and Safety.

Cureus·2026
Same author

A Trio of Atypical Ectopic Pregnancies.

JSLS : Journal of the Society of Laparoendoscopic Surgeons·2025
Same author

Accessibility to Obstetric Care in South Florida Based on Insurance: A Cross-Sectional Study.

Cureus·2023
Same author

Urinary diversion after exenterative surgery: continent conduit remains my ideal approach.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2020
Same author

Candidate Gene in Predicting In Vivo Ovarian Cancer Response to Combination Therapy with Paraplatin and Paclitaxel.

TheScientificWorldJournal·2018
Same author

Correlation of pretreatment drug induced apoptosis in ovarian cancer cells with patient survival and clinical response.

Journal of translational medicine·2012

Area of Science:

  • Gynecologic Oncology
  • Radiation Oncology
  • Medical Oncology

Background:

  • Recurrent vulvar cancer affects approximately 24% of cases post-primary treatment.
  • Limited randomized studies exist due to low recurrence rates, relying on retrospective data.
  • Traditional treatment emphasizes surgery, with recent advancements in chemoradiation.

Purpose of the Study:

  • To review and summarize current therapeutic modalities for recurrent vulvar cancer.
  • To highlight the importance of location and extent in treatment selection.
  • To discuss the role of surgery, radiation, and chemotherapy in managing recurrences.

Main Methods:

  • Review of retrospective studies and anecdotal evidence on vulvar cancer recurrence treatment.
  • Analysis of treatment outcomes based on recurrence site (local, regional lymph nodes, pelvic).
  • Evaluation of surgical techniques, radiation therapy, and chemotherapy regimens.

Main Results:

  • Lateralized local recurrences show high cure rates (70%) with wide radical local excision and lymphadenectomy.
  • Central pelvic recurrences may require pelvic exenteration, but chemoradiation with local excision can avoid this.
  • Regional lymph node recurrences have a poor prognosis; treatment involves excision with radiotherapy and chemosensitization, or brachytherapy if prior radiation exists.

Conclusions:

  • Treatment for recurrent vulvar cancer is tailored to the recurrence's location and extent.
  • Combining chemoradiation with surgery offers improved survival and reduced morbidity for advanced or central recurrences.
  • Further research and patient enrollment in clinical trials are needed, especially for distant metastases.

Related Experiment Videos